Skip to main contentSkip to navigation
Sirius Investors
Progyny, Inc.

Progyny, Inc.

PGNY
NASDAQHealthcare

Revenue Analysis - PGNY

Comprehensive quarterly and annual revenue breakdown by product lines and geographic regions to identify growth drivers and market opportunities.

PGNY Corporation

Annual

Revenue by Product Line

Latest quarterly revenue breakdown by product segments

Quarterly Product Revenue

Product Revenue Details

Detailed breakdown of revenue by product line

Fertility benefit services revenue

0.0% of total revenue

$209.4M

Pharmacy benefit services revenue

0.0% of total revenue

$119.1M

Historical Revenue Data

Quarterly product revenue breakdown over time (Last 6 records)

Date
Fertility benefit services revenue
Pharmacy benefit services revenue
3/31/2026$209.4M$119.1M
12/31/2025$208.6M$109.8M
9/30/2025$201.9M$111.4M
6/30/2025$213.9M$118.9M
3/31/2025$206.4M$117.6M
12/31/2024$381.0M$221.5M

Revenue Trend Analysis

Analysis of major growing and declining segments based on recent revenue data

Product Segments

Stable Segments
Fertility benefit services revenue+0.4%
Pharmacy benefit services revenue+8.5%

Earnings Reports

Want to see how PGNY's earnings relate to revenue? View quarterly earnings results, EPS history, and earnings surprises to understand the company's profitability.

View Earnings Reports